$Moleculin Biotech(MBRX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-04-24 AccNo: 0001144204-19-020802 Size: 317 KB 网页链接
$Moleculin Biotech(MBRX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-04-23 AccNo: 0001535610-19-000082 Size: 13 KB 网页链接
$Moleculin Biotech(MBRX)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-16 AccNo: 0001659617-19-000047 Size: 502 KB 网页链接
$Moleculin Biotech(MBRX)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2019-04-12 AccNo: 0001659617-19-000042 Size: 501 KB 网页链接
$Moleculin Biotech(MBRX)$ 8-K - Current report Filed: 2019-04-11 AccNo: 0001659617-19-000037 Size: 42 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Moleculin Biotech(MBRX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-04-08 AccNo: 0000919574-19-002792 Size: 117 KB 网页链接
$Moleculin Biotech(MBRX)$ PRE 14A - Other preliminary proxy statements Filed: 2019-04-05 AccNo: 0001659617-19-000033 Size: 493 KB 网页链接
$Moleculin Biotech(MBRX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-03-29 AccNo: 0001144204-19-016728 Size: 402 KB 网页链接
$Moleculin Biotech(MBRX)$ 8-K - Current report Filed: 2019-03-28 AccNo: 0001144204-19-016392 Size: 500 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Moleculin Biotech(MBRX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-03-26 AccNo: 0001144204-19-016030 Size: 402 KB 网页链接